Search for: "Clapp v. Clapp"
Results 41 - 56
of 56
Sorted by Relevance
|
Sort by Date
30 Jun 2012, 7:17 am
Ruff v. [read post]
8 Aug 2017, 8:36 am
Clapp, An Environmental History of Britain Since the Industrial Revolution (1994), at 194.) [read post]
19 Oct 2020, 4:19 am
The Doctrine of Common-Law Dissolution The doctrine of common-law dissolution dates back to a series of lower court opinions culminating in the Court of Appeals’ decision in Liebert v Clapp, 13 NY 2d 313 [1963]). [read post]
10 Jun 2012, 1:09 pm
Brock v. [read post]
10 Feb 2023, 4:44 am
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
28 May 2020, 5:29 am
Another vacuous response to a methodological challenge under Rule 702 is to label the challenge as “going to the weight, not the admissibility” of the challenged expert witness’s testimony. [read post]
12 Feb 2021, 12:59 pm
Carl Cranor pays me the dubious honor of quoting my assessment of weight of the evidence (WOE) pseudo-methodology as used by lawsuit industry expert witnesses, in one of his recent publications: “Take all the evidence, throw it into the hopper, close your eyes, open your heart, and guess the weight. [read post]
19 Nov 2023, 11:28 am
In Rost v. [read post]
26 Feb 2022, 6:53 pm
In a seminal 1977 discrimination case, Casteneda v. [read post]
24 May 2021, 3:56 am
Under the case law, common-law dissolution requires the minority shareholder to show, as articulated by the Court of Appeals in Leibert v Clapp, that “the directors and majority shareholders . . . so palpably breached the fiduciary duty they owe to the minority shareholders that they are disqualified from exercising the exclusive discretion and the dissolution power given to them by statute. [read post]
3 Nov 2014, 3:32 am
Demarest in Cortes v 3A N. [read post]
9 Jun 2018, 11:15 am
Milward v. [read post]
19 Jun 2022, 5:05 pm
In a seminal discrimination case, Casteneda v. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
17 Oct 2021, 2:17 pm
Kehm v. [read post]
9 Mar 2017, 9:06 am
Berkeley, California: A Vibrant Past I’m Ed Smith, a personal injury attorney in Berkeley. [read post]
